Results 71 to 80 of about 333,932 (156)

Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy

Frontiers in Cell and Developmental Biology
Cardiovascular–kidney–metabolic (CKM) syndrome represents a systemic disease continuum arising from the progressive and reciprocal interactions among metabolic dysfunction, kidney injury, and cardiovascular disease.
Fengzhao Liu, Zihan Xu, Wenru Wang, Junwei Gao, Changgeng Fu, Peng Liu   +5 more
doaj   +1 more source

Type-5 Cardiorenal Syndrome (CRS-5): An up to Date [PDF]

, 2017
Cardiorenal syndromes (CRS) involve disorders of the heart or kidney whereby one organ dysfunction leads to the dysfunction of another. Five types of CRS are defined.
A. Bellasi, Mario Cozzolino, M.G. Cozzolino, Antonio Bellasi, Claudio Ronco, C. Ronco, F. Sanoboni, Francesca Santoboni, Luca Di Lullo, Antonio Selvi, L. Di Lullo, A. Selvi   +11 more
core   +1 more source

Quality of Diabetes Care Among Older Adults in Germany—Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10018-10027, November 2026.
ABSTRACT Aims The study aims (1) to evaluate the quality of diabetes care considering guideline‐recommended medical therapies, cardiometabolic factors, and self‐management of health behaviours among older adults with diabetes in Germany, and (2) to examine time trends.
Yong Du, Giselle Sarganas, Beate Gaertner, Maike Buchmann, Judith Fuchs, Hannelore Neuhauser, Christin Heidemann   +6 more
wiley   +1 more source

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium‐Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10210-10217, November 2026.
ABSTRACT Aims Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are commonly withheld during hospitalisation because of concerns about diabetic ketoacidosis. We examined whether hospitalisation was associated with discontinuation of SGLT2i and compared patterns with another anti‐hyperglycaemic medicine without similar inpatient safety concerns ...
Tamara Y. Milder, Leah Shepherd, Hans Kristian Raket, Jerry R. Greenfield, Richard O. Day, Jialing Lin, Juliana de Oliveira Costa, Sophie Stocker, Carol A. Pollock, Brendon Neuen, Min Jun, Jane Ludington, Sallie‐Anne Pearson, Michael O. Falster   +13 more
wiley   +1 more source

CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease

Diabetology & Metabolic Syndrome
Background Metabolic Syndrome—a constellation of insulin resistance, cardiovascular risk factors as hyperglycemia, hypertension, and dyslipidemia, and systemic metabolic dysfunction—may be driven by dysregulation of adipose tissue, which manifests as ...
Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto, Andrei C. Sposito, José Hermógenes Rocco Suassuna   +5 more
doaj   +1 more source

Cardiorenal syndromes

, 2011
Cardiac and kidney diseases are very common, and increasingly coexist. Classification for cardiorenal syndrome and for its specific subtypes has been developed and published recently by a consensus group of the Acute Dialysis Quality Initiative ...
Tünde Pintér, Tibor Kovács, Balázs Sági, István Késői, István Wittmann, Tibor Vas, Judit Nagy   +6 more
core   +1 more source

Triglyceride-glucose index and reduced kidney function in hypertensive Nigerian adults: independent association within the cardio-renal continuum

BMC Cardiovascular Disorders
Background Reduced kidney function is a major contributor to cardiovascular morbidity and mortality worldwide, particularly among individuals with hypertension.
Casmir Ezenwa Amadi, Precious O. Akanbi, Micah Okwah, Amam C. Mbakwem, Jayne N. Ajuluchukwu   +4 more
doaj   +1 more source

Eurasian clinical guidelines for the diagnosis and treatment of cardiorenal syndrome (2026)

Евразийский Кардиологический Журнал
Cardiorenal syndrome (CRS) covers a spectrum of disorders affecting both the heart and kidneys, in which acute or chronic dysfunction in one organ can cause acute or chronic dysfunction in another organ.
Nataliya P. Mitkovskaya, Irina E. Chazova, Olga A. Sudzhaeva, Elena A. Grigorenko, Oleg V. Kalachik, Liana G. Shestakova, Elena Yu. Brankovskaya, Maria V. Smolyakova, Olga Iu. Trushina, Valery I. Podzolkov, Anna E. Bragina, Irina N. Bobkova, Oxana A. Kislyak, Viktor V. Fomin, Nataliya V. Blinova   +14 more
doaj   +1 more source

From Parallel Programming to Bidirectional Crosstalk: The Brain–Kidney Axis in Cardiovascular–Kidney–Metabolic Syndrome

Antioxidants
Cardiovascular–kidney–metabolic (CKM) syndrome is a systemic, interdependent disorder arising from the convergence of metabolic dysfunction, chronic kidney disease, and cardiovascular pathology. Anchored in the Developmental Origins of Health and Disease
Chien-Ning Hsu, You-Lin Tain
doaj   +1 more source

A New Era in the Management of Cardiorenal Syndrome: The Importance of Cardiorenal Units [PDF]

Introduction: Approximately 70% of patients with heart failure (HF) also have kidney disease. Mortality is increased both by cardiorenal syndrome (CRS) and by the exacerbation of other comorbidities.
Zamora Carrillo, Jorge Ivan, Natalia Ramos Terrades, Azancot Rivero, M Antonieta, Patricio-Liébana, Marc, Catarina Marouco, María Antonieta Azancot, Jorge Iván Zamora, Sara Núñez-Delgado, León-Román, Juan, Marc Patricio-Liebana, Soler, María José, Méndez Fernández, Ana Belén, TOAPANTA, NÉSTOR, Néstor Toapanta, Juan León-Román, Ana Belen Mendez Fernandez, Núñez Delgado, Sara, Ramos Terrades, Natalia, Marouço, Catarina, María José Soler   +19 more
core   +1 more source